
AC Immune SA ACIU
$ 2.65
-1.49%
Annual report 2023
added 02-15-2025
Country |
![]() |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Prof. Dr. Andrea Pfeifer |
Employees in the company |
115 |
Shares |
- |
Market Cap[1] |
$ 229 M |
EBITDA (LTM) |
$ -49.6 M |
P/E (LTM) |
- |
P/S (LTM) |
27.99 |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.